Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Maj 2023

Genmab — Maj 2023

Planlagt Fastgjort Låst Flyttet Genmab
490 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • troldmandenT Offline
    troldmandenT Offline
    troldmanden
    wrote on sidst redigeret af
    #110

    Så der sker ikke noget fordi så saver politikerne i den gren de sidder på

    1 Reply Last reply
    0
    • T Offline
      T Offline
      Teller
      wrote on sidst redigeret af
      #111

      Lækker udvikling... 🙂 🙂 🙂

      1 Reply Last reply
      0
      • nohopeN Offline
        nohopeN Offline
        nohope
        wrote on sidst redigeret af
        #112

        Med risiko for at blive tage fejl: hvis I skal have solgt,så er det nu, det her holder ikke til luk.

        1 Reply Last reply
        0
        • T Offline
          T Offline
          Teller
          wrote on sidst redigeret af
          #113

          Tror bare jeg holder fast lidt endnu... Har ikke solgt i15 år efterhånden, med undtagelse af skattehensyn.

          1 Reply Last reply
          0
          • CupcakeC Offline
            CupcakeC Offline
            Cupcake
            wrote on sidst redigeret af
            #114

            @Troldmanden - langt hen ad vejen er det pharmacy benefit managers (PBM), der bestemmer prisen, idet de tjener mere, jo mere medicinen koster. Patienterne taber. De lever en skjulet tilværelse. https://content.naic.org/cipr-topics/pharmacy-benefit-managers Også god forklarende artikel og video her... https://www.menendez.senate.gov/newsroom/press/sen-menendez-slams-pharmacy-benefits-managers-practices-that-prioritize-profits-and-drive-up-the-cost-of-prescription-drugs-for-patients

            1 Reply Last reply
            0
            • troldmandenT Offline
              troldmandenT Offline
              troldmanden
              wrote on sidst redigeret af
              #115

              Det er jeg heller ikke så overbevist om Nohope. Men hvis og såfremt de får godkendelsen, så bør den vel kunne bryde 3000. Måske over en periode derefter komme i nærheden af ATH.

              1 Reply Last reply
              0
              • troldmandenT Offline
                troldmandenT Offline
                troldmanden
                wrote on sidst redigeret af
                #116

                Cupcake ja det er grotesk. Pharma industrien har dog også ekstrem stor interesse i at det overordnet set er status quo. Hvis de kørte det med auktioner som i DK, så er de tæt på at kunne gå over til en en ren dansk model. Hvor ALLE har adgang til medicin uden meget dyre privat forsikringer

                1 Reply Last reply
                0
                • troldmandenT Offline
                  troldmandenT Offline
                  troldmanden
                  wrote on sidst redigeret af
                  #117

                  Men det kommer ikke til at ske. For det er jo social staten. Det værste skræmmebillede for R

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #118

                    New trial by Hoosier Cancer Research Network (Genmab collaborates) Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
                    https://clinicaltrials.gov/ct2/show/NCT05852717

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #119

                      nice to see other parties starting trials on your drug before it is even approved...

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #120

                        and another 2 arms for EPCORE NHL-2 - https://clinicaltrials.gov/ct2/history/NCT04663347?A=8&B=9&C=merged#StudyPageTop - Enrollment from 396 to 662 patients

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #121

                          @Legolas breaking the april 18 high of 2947 would confirm your cuphandle.. would target 3450ish if it can stay above that hurdle...

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #122

                            @Bulder can you try sending me a test
                            message here through proinvestor?

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #123

                              i think my main message from the earnings call, if you read between the lines, is that they seem to have much more going on pre-clinical than even i thought

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #124

                                they have done smaller deals we don't know about...

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #125

                                  they have interest from big pharma that they don't want to give in to because they want to stick to the 50/50 profit
                                  share (and i agree)

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #126

                                    he actually said a minimum of 50/50...

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #127

                                      we had a discussion on ADC mid april, and it seems we were spot on there; they are fully working on that and also with AbbVie as we suggested...

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #128

                                        Thx E L 🙂

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #129

                                          no problem 😉

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper